Company news
Oxurion Nv (EURONEXT:OXUR) news
Oxurion Nv news releases on 6ix. Latest, Sep 30, 2026: Oxurion : Interim Financial Report — Half-year results as of 30 June 2026 (EN)
Press releases & updates
Oxurion : Interim Financial Report — Half-year results as of 30 June 2026 (EN)
September 30, 2026
Oxurion Nv : Oxurion Publishes First Half 2026 Results
September 30, 2026
Oxurion Nv : Oxurion enters into exclusive negotiations to acquire the business and assets of Eclevar, a MedTech-focused CRO
September 30, 2026
Oxurion Nv : Oxurion expands its clinical research platform through strategic biometrics partnership between Axiodis CRO and KYomed INNOV
July 21, 2026
Oxurion Nv : Oxurion achieves another milestone in the expansion of the Exagis platform with the commercial launch of its eTMF module
July 6, 2026
Oxurion Nv : Oxurion launches a software-driven growth strategy with Exagis
June 8, 2026
Oxurion Nv : Oxurion Announces Results on the Annual Shareholders’ Meeting of 1 June 2026
June 3, 2026
Oxurion Nv : Oxurion expands its capabilities to address the growing demand for GLP-1 and peptide clinical research services
June 2, 2026
Oxurion Nv : Oxurion - Termination of discussions for the French CRO project (LOI dated 13/10/25) and prioritization of the international target (LOI dated 19/03/26)
June 2, 2026
Oxurion Nv : Publication Annual Report - Annual Shareholders Meeting
April 30, 2026
Oxurion Nv : Postponement Annual Shareholders Meeting
April 7, 2026
Oxurion Nv : Oxurion signs a letter of intent for the acquisition of an international CRO
March 19, 2026
Oxurion : Extends Its Financing Program
March 10, 2026
Oxurion : confirms continuation of discussions regarding its proposed acquisition of a French CRO
February 27, 2026
Oxurion Nv : Oxurion secures a binding EUR 30 million financing facility dedicated to investments in digital and crypto assets
December 1, 2025